IBDEI219 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32449,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32449,1,3,0)
;;=3^Retinal Artery Branch Occlusion,OU
;;^UTILITY(U,$J,358.3,32449,1,4,0)
;;=4^H34.233
;;^UTILITY(U,$J,358.3,32449,2)
;;=^5005566
;;^UTILITY(U,$J,358.3,32450,0)
;;=H34.8310^^128^1661^4
;;^UTILITY(U,$J,358.3,32450,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32450,1,3,0)
;;=3^BRVO,OD w/ Macular Edema
;;^UTILITY(U,$J,358.3,32450,1,4,0)
;;=4^H34.8310
;;^UTILITY(U,$J,358.3,32450,2)
;;=^5138488
;;^UTILITY(U,$J,358.3,32451,0)
;;=H34.8311^^128^1661^5
;;^UTILITY(U,$J,358.3,32451,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32451,1,3,0)
;;=3^BRVO,OD w/ Retinal Neovascularization
;;^UTILITY(U,$J,358.3,32451,1,4,0)
;;=4^H34.8311
;;^UTILITY(U,$J,358.3,32451,2)
;;=^5138489
;;^UTILITY(U,$J,358.3,32452,0)
;;=H34.8312^^128^1661^6
;;^UTILITY(U,$J,358.3,32452,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32452,1,3,0)
;;=3^BRVO,OD,Stable
;;^UTILITY(U,$J,358.3,32452,1,4,0)
;;=4^H34.8312
;;^UTILITY(U,$J,358.3,32452,2)
;;=^5138490
;;^UTILITY(U,$J,358.3,32453,0)
;;=H34.8320^^128^1661^7
;;^UTILITY(U,$J,358.3,32453,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32453,1,3,0)
;;=3^BRVO,OS w/ Macular Edema
;;^UTILITY(U,$J,358.3,32453,1,4,0)
;;=4^H34.8320
;;^UTILITY(U,$J,358.3,32453,2)
;;=^5138491
;;^UTILITY(U,$J,358.3,32454,0)
;;=H34.8321^^128^1661^8
;;^UTILITY(U,$J,358.3,32454,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32454,1,3,0)
;;=3^BRVO,OS w/ Retinal Neovascularization
;;^UTILITY(U,$J,358.3,32454,1,4,0)
;;=4^H34.8321
;;^UTILITY(U,$J,358.3,32454,2)
;;=^5138492
;;^UTILITY(U,$J,358.3,32455,0)
;;=H34.8322^^128^1661^9
;;^UTILITY(U,$J,358.3,32455,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32455,1,3,0)
;;=3^BRVO,OS,Stable
;;^UTILITY(U,$J,358.3,32455,1,4,0)
;;=4^H34.8322
;;^UTILITY(U,$J,358.3,32455,2)
;;=^5138493
;;^UTILITY(U,$J,358.3,32456,0)
;;=H34.8110^^128^1661^10
;;^UTILITY(U,$J,358.3,32456,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32456,1,3,0)
;;=3^CRVO,OD w/ Macular Edema
;;^UTILITY(U,$J,358.3,32456,1,4,0)
;;=4^H34.8110
;;^UTILITY(U,$J,358.3,32456,2)
;;=^5138476
;;^UTILITY(U,$J,358.3,32457,0)
;;=H34.8111^^128^1661^11
;;^UTILITY(U,$J,358.3,32457,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32457,1,3,0)
;;=3^CRVO,OD w/ Retinal Neovascularization
;;^UTILITY(U,$J,358.3,32457,1,4,0)
;;=4^H34.8111
;;^UTILITY(U,$J,358.3,32457,2)
;;=^5138477
;;^UTILITY(U,$J,358.3,32458,0)
;;=H34.8112^^128^1661^12
;;^UTILITY(U,$J,358.3,32458,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32458,1,3,0)
;;=3^CRVO,OD,Stable
;;^UTILITY(U,$J,358.3,32458,1,4,0)
;;=4^H34.8112
;;^UTILITY(U,$J,358.3,32458,2)
;;=^5138478
;;^UTILITY(U,$J,358.3,32459,0)
;;=H34.8120^^128^1661^13
;;^UTILITY(U,$J,358.3,32459,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32459,1,3,0)
;;=3^CRVO,OS w/ Macular Edema
;;^UTILITY(U,$J,358.3,32459,1,4,0)
;;=4^H34.8120
;;^UTILITY(U,$J,358.3,32459,2)
;;=^5138479
;;^UTILITY(U,$J,358.3,32460,0)
;;=H34.8121^^128^1661^14
;;^UTILITY(U,$J,358.3,32460,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32460,1,3,0)
;;=3^CRVO,OS w/ Retinal Neovascularization
;;^UTILITY(U,$J,358.3,32460,1,4,0)
;;=4^H34.8121
;;^UTILITY(U,$J,358.3,32460,2)
;;=^5138480
;;^UTILITY(U,$J,358.3,32461,0)
;;=H34.8122^^128^1661^15
;;^UTILITY(U,$J,358.3,32461,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32461,1,3,0)
;;=3^CRVO,OS,Stable
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI219 3790 printed Apr 09, 2024@21:18:03 Page 2
IBDEI219 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32449,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,32449,1,3,0)
+4 ;;=3^Retinal Artery Branch Occlusion,OU
+5 ;;^UTILITY(U,$J,358.3,32449,1,4,0)
+6 ;;=4^H34.233
+7 ;;^UTILITY(U,$J,358.3,32449,2)
+8 ;;=^5005566
+9 ;;^UTILITY(U,$J,358.3,32450,0)
+10 ;;=H34.8310^^128^1661^4
+11 ;;^UTILITY(U,$J,358.3,32450,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,32450,1,3,0)
+14 ;;=3^BRVO,OD w/ Macular Edema
+15 ;;^UTILITY(U,$J,358.3,32450,1,4,0)
+16 ;;=4^H34.8310
+17 ;;^UTILITY(U,$J,358.3,32450,2)
+18 ;;=^5138488
+19 ;;^UTILITY(U,$J,358.3,32451,0)
+20 ;;=H34.8311^^128^1661^5
+21 ;;^UTILITY(U,$J,358.3,32451,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,32451,1,3,0)
+24 ;;=3^BRVO,OD w/ Retinal Neovascularization
+25 ;;^UTILITY(U,$J,358.3,32451,1,4,0)
+26 ;;=4^H34.8311
+27 ;;^UTILITY(U,$J,358.3,32451,2)
+28 ;;=^5138489
+29 ;;^UTILITY(U,$J,358.3,32452,0)
+30 ;;=H34.8312^^128^1661^6
+31 ;;^UTILITY(U,$J,358.3,32452,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,32452,1,3,0)
+34 ;;=3^BRVO,OD,Stable
+35 ;;^UTILITY(U,$J,358.3,32452,1,4,0)
+36 ;;=4^H34.8312
+37 ;;^UTILITY(U,$J,358.3,32452,2)
+38 ;;=^5138490
+39 ;;^UTILITY(U,$J,358.3,32453,0)
+40 ;;=H34.8320^^128^1661^7
+41 ;;^UTILITY(U,$J,358.3,32453,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,32453,1,3,0)
+44 ;;=3^BRVO,OS w/ Macular Edema
+45 ;;^UTILITY(U,$J,358.3,32453,1,4,0)
+46 ;;=4^H34.8320
+47 ;;^UTILITY(U,$J,358.3,32453,2)
+48 ;;=^5138491
+49 ;;^UTILITY(U,$J,358.3,32454,0)
+50 ;;=H34.8321^^128^1661^8
+51 ;;^UTILITY(U,$J,358.3,32454,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,32454,1,3,0)
+54 ;;=3^BRVO,OS w/ Retinal Neovascularization
+55 ;;^UTILITY(U,$J,358.3,32454,1,4,0)
+56 ;;=4^H34.8321
+57 ;;^UTILITY(U,$J,358.3,32454,2)
+58 ;;=^5138492
+59 ;;^UTILITY(U,$J,358.3,32455,0)
+60 ;;=H34.8322^^128^1661^9
+61 ;;^UTILITY(U,$J,358.3,32455,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,32455,1,3,0)
+64 ;;=3^BRVO,OS,Stable
+65 ;;^UTILITY(U,$J,358.3,32455,1,4,0)
+66 ;;=4^H34.8322
+67 ;;^UTILITY(U,$J,358.3,32455,2)
+68 ;;=^5138493
+69 ;;^UTILITY(U,$J,358.3,32456,0)
+70 ;;=H34.8110^^128^1661^10
+71 ;;^UTILITY(U,$J,358.3,32456,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,32456,1,3,0)
+74 ;;=3^CRVO,OD w/ Macular Edema
+75 ;;^UTILITY(U,$J,358.3,32456,1,4,0)
+76 ;;=4^H34.8110
+77 ;;^UTILITY(U,$J,358.3,32456,2)
+78 ;;=^5138476
+79 ;;^UTILITY(U,$J,358.3,32457,0)
+80 ;;=H34.8111^^128^1661^11
+81 ;;^UTILITY(U,$J,358.3,32457,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,32457,1,3,0)
+84 ;;=3^CRVO,OD w/ Retinal Neovascularization
+85 ;;^UTILITY(U,$J,358.3,32457,1,4,0)
+86 ;;=4^H34.8111
+87 ;;^UTILITY(U,$J,358.3,32457,2)
+88 ;;=^5138477
+89 ;;^UTILITY(U,$J,358.3,32458,0)
+90 ;;=H34.8112^^128^1661^12
+91 ;;^UTILITY(U,$J,358.3,32458,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,32458,1,3,0)
+94 ;;=3^CRVO,OD,Stable
+95 ;;^UTILITY(U,$J,358.3,32458,1,4,0)
+96 ;;=4^H34.8112
+97 ;;^UTILITY(U,$J,358.3,32458,2)
+98 ;;=^5138478
+99 ;;^UTILITY(U,$J,358.3,32459,0)
+100 ;;=H34.8120^^128^1661^13
+101 ;;^UTILITY(U,$J,358.3,32459,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,32459,1,3,0)
+104 ;;=3^CRVO,OS w/ Macular Edema
+105 ;;^UTILITY(U,$J,358.3,32459,1,4,0)
+106 ;;=4^H34.8120
+107 ;;^UTILITY(U,$J,358.3,32459,2)
+108 ;;=^5138479
+109 ;;^UTILITY(U,$J,358.3,32460,0)
+110 ;;=H34.8121^^128^1661^14
+111 ;;^UTILITY(U,$J,358.3,32460,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,32460,1,3,0)
+114 ;;=3^CRVO,OS w/ Retinal Neovascularization
+115 ;;^UTILITY(U,$J,358.3,32460,1,4,0)
+116 ;;=4^H34.8121
+117 ;;^UTILITY(U,$J,358.3,32460,2)
+118 ;;=^5138480
+119 ;;^UTILITY(U,$J,358.3,32461,0)
+120 ;;=H34.8122^^128^1661^15
+121 ;;^UTILITY(U,$J,358.3,32461,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,32461,1,3,0)
+124 ;;=3^CRVO,OS,Stable
